Prenatal Screening and Diagnostics
Prenatal Screening and Diagnostics is a research topic within Pediatrics, Perinatology and Child Health. Science Explorer counts 40k research works in it since 1950. 21.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the various techniques and methods for diagnosing and screening prenatal aneuploidy, including the use of maternal plasma DNA sequencing, noninvasive prenatal testing, preimplantation genetic diagnosis, and fetal DNA analysis. It also covers topics such as chromosomal abnormalities, trisomy detection, and genomic sequencing in the context of prenatal diagnosis.
- Prenatal Diagnosis
- Aneuploidy Screening
- Maternal Plasma DNA Sequencing
- Noninvasive Prenatal Testing
- Chromosomal Abnormalities
- Preimplantation Genetic Diagnosis
- Fetal DNA Analysis
- Cell-Free DNA
- Trisomy Detection
- Genomic Sequencing
- Research works
- 40k fractional, since 1950
- In the world top 10%
- 8.8k per year above
- Top-10% rate
- 21.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +13% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Prenatal Screening and Diagnostics research?
By volume, the United States and China publish the most (1.4k and 793 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.4k works
- 2 China 793 works
- 3 India 329 works
- 4 United Kingdom 253 works
- 5 Italy 193 works
- 6 Canada 153 works
- 7 Spain 151 works
- 8 Brazil 147 works
- 9 Japan 146 works
- 10 Germany 145 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Prenatal Screening and Diagnostics research?
By volume in 2022–2025, Harvard University publishes the most Prenatal Screening and Diagnostics research, followed by University of North Carolina at Chapel Hill and Yale University.
By volume, 2022–2025
- 1 Harvard UniversityUnited States 25 works
- 2 University of North Carolina at Chapel HillUnited States 22 works
- 3 Yale UniversityUnited States 21 works
- 4 Baylor College of MedicineUnited States 21 works
- 5 University of California, San FranciscoUnited States 21 works
- 6 Guangzhou Medical UniversityChina 19 works
- 7 China Medical UniversityTaiwan 18 works
- 8 Fujian Medical UniversityChina 18 works
- 9 Children's Hospital of PhiladelphiaUnited States 17 works
- 10 University of PennsylvaniaUnited States 17 works
Who are the leading researchers in Prenatal Screening and Diagnostics?
The most-cited researchers publishing on Prenatal Screening and Diagnostics include Andrew P. Feinberg.
- 1 Andrew P. Feinberg United States 4.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Prenatal Screening and Diagnostics research done?
The largest centres of Prenatal Screening and Diagnostics research in 2022–2025 are New York (United States), London (United Kingdom), Beijing (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Taichung and Tel Aviv.
Largest cities, 2022–2025
Where it is the local speciality
- TaichungTW · 42.1 works8.5×
- Tel AvivIL · 25.0 works6.0×
Location quotient: how much more of its research is in Prenatal Screening and Diagnostics than the world average.
Where is the best place to study Prenatal Screening and Diagnostics?
Among universities, judged by research, Baylor College of Medicine, Fujian Medical University and Guangzhou Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Baylor College of MedicineUnited States | 62.1 | 23.3% | 9.9× | 21 | +71.1% |
| 2 | Fujian Medical UniversityChina | 58.8 | 28.2% | 9.4× | 18 | +59.4% |
| 3 | Guangzhou Medical UniversityChina | 58.3 | 23.3% | 13.3× | 19 | +33.8% |
| 4 | China Medical UniversityTaiwan | 55.6 | 18.1% | 24.0× | 18 | -42.8% |
| 5 | Harvard UniversityUnited States | 54.5 | 31.7% | 3.7× | 25 | +23.2% |
| 6 | University of California, San FranciscoUnited States | 51.0 | 28.2% | 6.2× | 21 | -11.4% |
| 7 | Tel Aviv UniversityIsrael | 48.2 | 25.9% | 5.4× | 16 | +56.1% |
| 8 | KU LeuvenBelgium | 44.9 | 33.5% | 3.1× | 15 | -1.2% |
| 9 | University College LondonUnited Kingdom | 43.6 | 39.8% | 2.0× | 14 | -21.8% |
| 10 | Nanjing Medical UniversityChina | 42.7 | 39.4% | 4.2× | 11 | +32.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Prenatal Screening and Diagnostics research growing?
Output in 2018–2022 was 13% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Prenatal Screening and Diagnostics.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.